Understanding Pay For Performance and DIR Impact to Pharmacy Reimbursement

Similar documents
DIR FEES: WHAT YOU NEED TO KNOW JULY 13, :00 10:00 AM

DIR fees are knocking down pharmacy profits

DIR: Trends, Issues, and Impending Impacts

Implement a definition of negotiated price to include all pharmacy price concessions.

The Impact of Adherence Quality Measures on the US Healthcare Marketplace

How Medication Adherence and Outcomes Are Changing the Business Model

STAR RATINGS PBM PARTNERSHIP, MAXIMUM RESULTS. Michelle Juhanson, CHC, CHPC Director of Compliance and Quality PerformRx

How you are being measured by health plans, PBMs and accreditation organizations. December 2013

Medicare 2017 Part C & D Star Rating Technical Notes

Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Presented January 20 th by Pharmacy Healthcare Solu7ons, Inc. Don Dietz, R.Ph, MS, Vice President

CMS Medicare Advantage 2018 Advance Notice Summary

Fact Sheet Part C and D Star Ratings

January 16, Ms. Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Blvd. Baltimore, Maryland 21244

Medicare Advantage: Early Views and Trend Spotting: What We Know From Analyzing Public Data Files

Summary of Benefits for Blue MedicareRx Standard SM (PDP), Blue MedicareRx Plus SM (PDP) and Blue MedicareRx Premier SM (PDP)

Provisions of the Medicare Modernization Act

Medicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014

Medicare Advantage Value-Based Insurance Design: Considerations and implications

I. PURPOSE. A. The primary objectives of Molina Healthcare s Transition Policy and Procedure are:

National Conference of State Legislatures Impact of Medicare Modernization and New Accounting Rules on States as Employers and Plan Sponsors

Understanding Your Medicare Options. Medicare Made Clear

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

MEDICARE PLAN PAYMENT GROUP

Linking Performance and Compliance: How Part D Quality Measures Relate to Plan Performance

MEDICARE PLAN PAYMENT GROUP

WorldatWork You and Your PBM: Improving Discounts, Fees and Rebates, and Beyond. Kristin Begley, Pharm.D. Principal

Medicaid Prescribed Drug Program. Spending Control Initiatives

Introduction to Medicare Parts C and D

Part II: Medicare Part C and Part D

2017 Number of Contracts. Weighted by Enrollment

Session 64PD, Risk-Sharing Arrangements in Medicare Advantage

Special Report: Medicare Part D. A Research Resource with Insights into. Medicare Part D

PACE & Medicare Part D

Part D Performance Audits - Formulary Administration

MedicAre: don t delay. apply for Medicare as soon as you become eligible. You ve earned it. Make the most of it.

Seeing Stars in Puerto Rico

Pharmacy Benefit Managers Overview

Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry

Eligibility and Enrollment in the Medicare Prescription Drug Program

2019 Transition Policy

Low Income Health Program Performance Dashboard CMSP

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Low Income Health Program Performance Dashboard Riverside

summary of benefits Blue Shield of California Medicare Rx Plan (PDP)

Released: February 19, Comments Due: March 4, 2016

Low Income Health Program Performance Dashboard Santa Cruz

Specialty Pharmacy: A Key to Organizational Success in Population Health Management

Summary of Benefits. Aetna Medicare Rx Costco Plus Plan (PDP) S5810. California. January 1, 2010 to December 31, 2010

Impact of H.R. 1038/S. 413 on CMS Payments Under Part D

Low Income Health Program Performance Dashboard San Diego

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.

Low Income Health Program Performance Dashboard Orange

Summary of CY2019 Proposed Medicare Advantage and Part D Policy & Technical Changes

Business & Financial Services December 2017

Summary of Benefits. January 1 December 31, 2011

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

PREMIUM IMPACT OF REMOVING MANUFACTURER REBATES FROM THE MEDICARE PART D PROGRAM

Medicare Updates. Illinois Department on Aging Senior Health Insurance Program (SHIP)

2019 Benefits. Emeriti Retirement Health TIM LANE PRESIDENT AND CEO OF EMERITI HEAD OF TIAA HEALTH

Annual Compliance Deadlines for Health Plans

Part D: The New Medicare Prescription Drug Law Implications for Medicaid

American Health Lawyers Association Medicare Advantage and Part D: Plan Provider Relationships in Light of Recent CMS Enforcement Actions

Low Income Health Program Performance Dashboard San Mateo

ACHIA Operations Report

Community Care, Inc. Medicare Part-D Enrollee Transition Plans H5212 PACE and H2034 HMO-SNP 2018

MEDICARE PART D POLICY FORMULARY: TRANSITION PROCESS Policy Number: 6-C

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

2011 Summary of Benefits

Medicare Part D: Retiree Drug Subsidy

Released: November 16, Comments Due: January 16, 2018

2020 Medicare Advantage

Prescription Drug Rebates and Part D Drug Costs

2017 Medicare Advantage and Prescription Drug Overview. Module 2

Healthy Michigan Plan signing, September 2013

Low Income Health Program Performance Dashboard Tulare

Summary of Benefits. Regence Medicare Script TM. Enhanced (PDP) Basic (PDP) Medicare Prescription Drug Plan for Utah

(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)

2010 Summary of Benefits S5601

2012 Medi-Pak Rx (PDP) Prescription Drug Plans. S5795_REV_RX_FF_KIT_10_11 CMS Approved This is an advertisement.

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

2017 Group Retiree Medicare Plans

Support and pass provider status legislation in the House and Senate (H.R. 592/S. 109).

Your 2017 Kaiser Permanente Guide to Medicare. Kaiser Permanente Senior Advantage (HMO) Kaiser Permanente Medicare Plus (Cost) Y0043_N accepted

Appendix. Year Total drug spending reaching catastrophic coverage, $

Understanding Private- Sector Medicare

Medicare Modernization Act (MMA)

Medicare Health & Drug Plan Quality and Performance Ratings 2012 Part C & Part D Technical Notes. First Plan Preview DRAFT

SELF-FUNDED PPO HEALTH PLAN RATE REQUIREMENTS RETIREES JANUARY 1, 2017 DECEMBER 31, 2017 COUNTY OF ORANGE JUNE 2016

2019 Transition Policy and Procedure

AHLA. L. Medicare Advantage New Developments and Key Legal Issues. Anne W. Hance McDermott Will & Emery LLP Washington, DC

All Medicare Advantage Products with Part D Benefits

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

Assessing the Medicare Advantage Star Ratings

Population Health and Wellness: 2 Stories from Cleveland Clinic. Elizabeth Sump Senior Director, Health Policy Cleveland Clinic

Policy Evaluation: HB 2126 Oregon Health Plan Preferred Drug List Enforcement and Voluntary Mental Health Preferred Drug List

Prescription Medicines: Costs in Context. Updated August 2016

VALUE-BASED PAYMENTS, STAR RATINGS AND THE LESSONS OF MEDICARE ADVANTAGE. A Presentation to the 11 th Annual Value-Based Payment and P4P Summit

Transcription:

Understanding Pay For and DIR Impact to Pharmacy Reimbursement

A Public Service Announcement brought to you by Melanie Maxwell, MHP Vice President RxSelect Pharmacy Services

Please Don t Shoot the Messenger PBMs PBMs

Why Plans/PBMs Embrace Pay for? Increased market pressure to control costs and increase profitability.

How Do Plans/PBMs Benefit From Pay for? Increased Beneficiary Enrollment Star Rated plans have certain marketing and enrollment advantages over lower rated plans. Members in a low rated plan can switch to a star rated plan at any time throughout the year, not just during open enrollment. CMS star ratings have been shown to influence Medicare beneficiaries choice of a plan. Increased Revenue MA PD Plans achieving star ratings of 4 ( above average ) or ( excellent ) receive quality bonus payments, which can potentially represent millions of dollars in revenue.

Let s Take A Look at Some P4P Contract Examples

Example A: Pay for Payment How the is d Diabetes PDC Target: 8% Pharmacy Percentile Ranking RASA PDC Target: 8% Pharmacy Percentile Ranking Cholesterol PDC Target: 83% Pharmacy Percentile Ranking 8.27% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% 0 9 8 7 6 4 3 2 83.2% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% 0 9 8 7 6 4 3 2 84.4% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% 0 9 8 7 6 4 3 2

Example A: Pay for Payment How the Dollars Work #of patients by Diabetes 0 40 400 RASA 9 0 40 Cholesterol 0 3 30 Total 2 200 Weighted Overall 200/2 = 9.6 Overall Payment Pharmacy Overall 9.6 Overall =>9 to 0 =>8 to <9 =>7 to < 8 =>6 to < 7 => to <6 =>4 to < =>3 to <4 =>2 to <3 => to <2 $.4 $3.79 $2.44 $.09 $9.74 $0.00 $0.00 $0.00 $0.00 $0.00 Payment Calculation $.4 Multiplied by Patient 2 Count Total Payment Available $,892.0 Less MTM Payments [$200.00] Payment Due Pharmacy $,692.0

Example B: Pay for Commercial and Medicaid Plans (Optional Plan Participation) Payment How the is d Diabetes PDC Congestive Heart Failure Non RASA Hypertension Respiratory PDC RASA PDC Coronary Artery Disease PDC Breast Cancer PDC Depression PDC Each is evaluated individually and then weighted by number of patients by pharmacy. Cholesterol PDC Osteoporosis PDC Behavioral Health PDC Pharmacy (Each ) Pharmacy Target Percentile Ranking Diabetes Congestive Heart Failure Non RASA Hypertension Respiratory RASA Coronary Artery Disease Breast Cancer Depression Cholesterol Osteoporosis Behavioral Health 8.7% 66.% 66.6% 7% 83.2% 40% 83.2%.7% 84.4% 78.4% 00% 8% 84% 70% 8% 86% 8% 83% 78% =>90% to 00% =>80% to <90% =>70% to < 80% =>60% to < 70% =>0% to <60% =>40% to <0% =>30% to <40% =>20% to <30% =>0% to <20% => 0% to <0% 0 9 8 7 6 4 3 2

Example B: Pay for Commercial and Medicaid Plans (Optional Plan Participation) Payment How the Dollars Work Perf. #of patients by Weighted Perf. Diabetes 0 40 400 CHF 8 0 400 Non RASA 6 3 20 Respiratory 0 30 300 RASA 8 40 320 CAD 2 0 00 Breast Cancer 8 0 80 Depression 2 0 20 Cholesterol 0 0 00 Osteoporosis 6 20 20 Behavioral Health 0 20 200 Total 3 260 Overall 260/3 = 7.46 Overall Payment Pharmacy Overall 7.46 Overall =>9 to 0 =>8 to <9 =>7 to < 8 =>6 to < 7 => to <6 =>4 to < =>3 to <4 =>2 to <3 => to <2 $.0 $0.4 $9.40 $8.3 $7.30 $0.00 $0.00 $0.00 $0.00 $0.00 Payment Calculation $9.40 Multiplied by Patient 3 Count Total Payment Available $3,337.00 Less MTM Payments [$200.00] Payment Due Pharmacy $3,37.00

Example C: Pay for Payments by Reduced DIR Fees A New Type of Network Program has been developed. It contains three components:. Payment scores for key adherence measures 2. DIR Fee Reduction individual pharmacy performance determines level of DIR assessed. 3. Re Credentialing and Attestation Requirement pharmacy must complete recredentialing requirements AND complete Medicare program attestations by end of year.

What is DIR?...Direct and Indirect Remuneration Paraphrased Definition from CMS 42 CFR Section 423.308 any and all rebates, subsidies, or other price concessions from any source Including manufacturers, pharmacies, enrollees, or any other person or entity) that serve to decrease the costs incurred by the Part D sponsor (whether directly or indirectly) for the Part D drug. -includes price concessions from manufacturers received by subcontractors of Part D sponsors, such as PBM. May include risk-sharing arrangements, generic dispensing incentive payments made after the point-of-sale.

What is DIR?...Direct and Indirect Remuneration The Real Reason Plans (PBMs) like DIR When calculating a Plan s risk share with CMS: Higher percent of the DIR fee is used to reduce a Plan s administrative costs instead of being applied directly to drug cost.

Example C: Pay for Based DIR Fee Reduction How s are d Category ACE/ARB Statin Diabetes GAP Therapy (statin) CMR Completion Rate % High Risk Meds Formulary Compliance Weight 20% 20% 20% 2% % % % DIR Fee (% of IngCost Paid) 3.% 4 4.0% 3 4.% 2.0%.% NOTE: DIR Fees are deducted from 83 Remittance Advice. You do not see DIR fees on the adjudicated claim response.

Example C: Pay for Based DIR Fee Reduction How the Dollars Work Category Weight Pharmacy A Pharmacy B ACE/ARB Statin Diabetes GAP Therapy (statin) CMR Completion Rate % High Risk Meds Formulary Compliance 20% 20% 20% 2% % % % Weighted Average

Example C: Pay for Based DIR Fee Reduction How the Dollars Work Impact to Reimbursement Esomeprazole 40mg Pharmacy A Pharmacy B Ingredient Cost Paid $229.98 $229.98 Dispense Fee Paid $.00 $.00 Patient Copay $0.00 $0.00 Total Amount Paid $220.98 $220.98 DIR Fee $8.0 $2.6 Total Net Reimbursement $22.93 $208.33 $4.60 variance on reimbursement due to performance

Example D: Pay for Payment How the Dollars Work Generic Dispense Rate Extended Day Dispense Rate High Risk Meds Pharmacy GDR Target Range Pharmacy EDS Target Range Pharmacy Target Goal 86.4% 87.9% 86% to 87.9% 84% to 8.9% 82% to 83.9% <82% 4 3 2.4% 8% % to 7.9% 3% to.9% 0% to 2.9% <0% 4 3 2 8.9% 7% 7.% to 9% 9.% to 3% 3.% to 7% 7.% 4 3 2

Example D: Pay for Payment How the Dollars Work Retro DIR Adjustment Lump Sum Adjustment on Remittance Advice #of patients by Average Calculation GDR 4 EDS 2 High Risk Meds 4 Overall 3.33 Overall Payment Pharmacy Overall 3.33 Average Pharmacy Range.0 4.0 to 4.9 3.0 to 3.9 2.0 to 2.9.0 to.9 DIR Fee $2.00 $2.0 $3.00 $3.0 $4.00 ment Period Month DIR Payable Q 206 (Jan Mar) June 206 Q2 206 (Apr Jun) Sept 206 Q3 206 (Jul Sep) Dec 206 Q4 206 (Oct Dec) March 207

If Only PBMs Were Paid for

If Only PBMs Were Paid for

THANK YOU!